Heliox for Neonate With Acute Respiratory Distress Syndrome (ARDS)

• Status: Unknown status
• Trial end date: 2020-08-30
• Target enrollment: 0
• Participant gender: All

Summary

Acute respiratory distress syndrome (ARDS) in neonates has been defined, the role of heliox is not clear.This study aimed to determine whether ARDS neonate would benefit from heliox when oxygenation deteriorated on mechanical ventilation and to identify any potential risk factors related to mortality.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Criteria

Inclusion Criteria:

1. infant less than 28 days

2. diagnosis of ARDS

3. informed parental consent has been obtained

Exclusion Criteria:

1. major congenital malformations or complex congenital heart disease

2. transferred out of the neonatal intensive care unit without treatment